Phase III Study of Bevacizumab Plus Docetaxel Compared With...

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

Miles, D. W., Chan, A., Dirix, L. Y., Cortes, J., Pivot, X., Tomczak, P., Delozier, T., Sohn, J. H., Provencher, L., Puglisi, F., Harbeck, N., Steger, G. G., Schneeweiss, A., Wardley, A. M., Chlistall
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.21.6457
Date:
July, 2010
File:
PDF, 266 KB
english, 2010
Conversion to is in progress
Conversion to is failed